Cargando…
Recent advances in the understanding of Dupuytren’s disease
Dupuytren’s disease (DD) is a common fibrotic disorder of the hand and can significantly impair hand function. Although the exact pathogenesis of this disorder remains to be elucidated, immunological, genetic and cellular factors likely interact. In this review, we summarise recent advances in the u...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396840/ https://www.ncbi.nlm.nih.gov/pubmed/30854193 http://dx.doi.org/10.12688/f1000research.17779.1 |
_version_ | 1783399330500050944 |
---|---|
author | Layton, Thomas Nanchahal, Jagdeep |
author_facet | Layton, Thomas Nanchahal, Jagdeep |
author_sort | Layton, Thomas |
collection | PubMed |
description | Dupuytren’s disease (DD) is a common fibrotic disorder of the hand and can significantly impair hand function. Although the exact pathogenesis of this disorder remains to be elucidated, immunological, genetic and cellular factors likely interact. In this review, we summarise recent advances in the understanding of DD pathogenesis and look to the future for potential novel therapeutic targets. In addition, we discuss the therapeutic options in DD with a focus on the need for more rigorous evidence to allow a meaningful comparison of different treatment modalities. |
format | Online Article Text |
id | pubmed-6396840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-63968402019-03-07 Recent advances in the understanding of Dupuytren’s disease Layton, Thomas Nanchahal, Jagdeep F1000Res Review Dupuytren’s disease (DD) is a common fibrotic disorder of the hand and can significantly impair hand function. Although the exact pathogenesis of this disorder remains to be elucidated, immunological, genetic and cellular factors likely interact. In this review, we summarise recent advances in the understanding of DD pathogenesis and look to the future for potential novel therapeutic targets. In addition, we discuss the therapeutic options in DD with a focus on the need for more rigorous evidence to allow a meaningful comparison of different treatment modalities. F1000 Research Limited 2019-02-28 /pmc/articles/PMC6396840/ /pubmed/30854193 http://dx.doi.org/10.12688/f1000research.17779.1 Text en Copyright: © 2019 Layton T and Nanchahal J http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Layton, Thomas Nanchahal, Jagdeep Recent advances in the understanding of Dupuytren’s disease |
title | Recent advances in the understanding of Dupuytren’s disease |
title_full | Recent advances in the understanding of Dupuytren’s disease |
title_fullStr | Recent advances in the understanding of Dupuytren’s disease |
title_full_unstemmed | Recent advances in the understanding of Dupuytren’s disease |
title_short | Recent advances in the understanding of Dupuytren’s disease |
title_sort | recent advances in the understanding of dupuytren’s disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396840/ https://www.ncbi.nlm.nih.gov/pubmed/30854193 http://dx.doi.org/10.12688/f1000research.17779.1 |
work_keys_str_mv | AT laytonthomas recentadvancesintheunderstandingofdupuytrensdisease AT nanchahaljagdeep recentadvancesintheunderstandingofdupuytrensdisease |